| 000 | 01590 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514215835.0 | ||
| 264 | 0 | _c20060207 | |
| 008 | 200602s 0 0 eng d | ||
| 022 | _a0091-2700 | ||
| 024 | 7 |
_a10.1177/0091270004270260 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMortensen, Deborah L | |
| 245 | 0 | 0 |
_aPharmacokinetics and pharmacodynamics of multiple weekly subcutaneous efalizumab doses in patients with plaque psoriasis. _h[electronic resource] |
| 260 |
_bJournal of clinical pharmacology _cMar 2005 |
||
| 300 |
_a286-98 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 | _aAntigen-Antibody Reactions |
| 650 | 0 | 4 |
_aCD11a Antigen _ximmunology |
| 650 | 0 | 4 | _aDown-Regulation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLeukocyte Count |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPsoriasis _xblood |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 700 | 1 | _aWalicke, Patricia A | |
| 700 | 1 | _aWang, Xiaolin | |
| 700 | 1 | _aKwon, Paul | |
| 700 | 1 | _aKuebler, Peter | |
| 700 | 1 | _aGottlieb, Alice B | |
| 700 | 1 | _aKrueger, James G | |
| 700 | 1 | _aLeonardi, Craig | |
| 700 | 1 | _aMiller, Bruce | |
| 700 | 1 | _aJoshi, Amita | |
| 773 | 0 |
_tJournal of clinical pharmacology _gvol. 45 _gno. 3 _gp. 286-98 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/0091270004270260 _zAvailable from publisher's website |
| 999 |
_c15379650 _d15379650 |
||